Abu Dhabi, United Arab Emirates - Sunday, June 23rd 2013 [ME NewsWire]

The Ministry of Interior started the registration process for the E-gate Project at the Abu Dhabi Mall Center today. The registration is applicable for citizens of the UAE and the GCC, in addition to residents who have an entry visa (from the port). Registration will continue until next Thursday.

Major Mohammad Ahmad Al Zaabi, Director of the E-port Project, stated that registration begins at 10 a.m. and concludes at 10 p.m. He further noted that it is free-of-charge.

He added that those wishing to register should bring their passports. The Ministry of Interior has allocated special counters for women; there are other counters for individuals with special needs at the Abu Dhabi Mall Center. Emirati citizens have a separate counter, and there are three counters for residents and visitors.

He said that the project is part of the Ministry of Interior’s efforts to realize success in the e-gov ... Read more »

Funding supports global efforts to strengthen communities, promote well-being, and protect our environment

ATLANTA - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Coca-Cola Foundation -- the global philanthropic arm of The Coca-Cola Company -- awarded US$36 million in grants to 105 community organizations during the first quarter of 2013. The grants support the Foundation’s global priority areas and the Company’s three-part sustainability approach, focused on enhancing people’s well-being, building strong communities and protecting the environment.

"Coca-Cola wants to be a positive force in communities around the world,” said Lisa M. Borders, Chair of The Coca-Cola Foundation and Vice President of Global Community Connections for The Coca-Cola Company. "Through these grants, we have an amazing opportunity to make a real difference for millions of people by supporting personal well-being programs, improving access to critical natural resources such a ... Read more »

Charlie Denson, président de la marque, partira en retraite en 2014

BEAVERTON, Oregon - Dimanche 23 Juin 2013 [ME NewsWire]

(BUSINESS WIRE)--NIKE, Inc. (NYSE : NKE) a annoncé aujourd'hui que Charlie Denson, président de la marque NIKE depuis 2006 et fort de 34 années d'ancienneté avec la marque, partira en retraite en janvier 2014. Parallèlement à cette décision de Denson de partir en retraite, la société a également annoncé des changements stratégiques dans son équipe de direction, dans le cadre de la stratégie d'organisation à long terme de la société visant à positionner l'entreprise de manière à continuer de promouvoir la croissance. Les changements reflètent la focalisation de la société sur le consommateur, par l'accélération de l'innovation, la promotion de la conception, l'alignement de l'excellence des produits et du marchandisage, ... Read more »

Control campaigns Intensified to promote safety

ABU DHABI, United Arab Emirates - Saturday, June 22nd 2013 [ME NewsWire]

In line with the traffic safety strategy’s priority to make roads safer, the Traffic and Patrols Directorate at Abu Dhabi Police intensified the monitoring and traffic control on trucks traveling the Abu Dhabi – Al Sila road.  This also comes in line with the two campaigns (Summer Without Accidents) and (Keeping Truck Drivers Safe and Sound) launched by the Directorate, to reduce the various causes of traffic accidents, particularly  during this time  of the year when  roads witness traffic density .

Major Suhail Sayah Al Mazrouei, Head of the Western Region Traffic section at the Traffic and Patrols Directorate of Abu Dhabi Police, indicated that the traffic control campaigns cover (compliance with traffic laws, tires validity, observing speed limits, load capacity and maintaining safe distance). It also includes tightening ... Read more »

Une étude visant à comparer la thérapie par pression négative traditionnelle à la thérapie avec instillation V.A.C. VeraFlo™, utilisant le système de thérapie par pression négative V.A.C.Ulta™

SAN ANTONIO - Dimanche 23 Juin 2013 [ME NewsWire]

(BUSINESS WIRE)--La société Kinetic Concepts, Inc. a annoncé aujourd'hui qu'elle avait commencé le recrutement de patients dans une étude clinique multicentrique évaluant les bienfaits de la thérapie par pression négative (TPN) avec une thérapie d'instillation intermittente utilisant un nettoyant de plaie topique. L'étude randomisée, contrôlée et prospective engage six centres de recherche à travers les États-Unis et compare la thérapie TPN traditionnelle avec le système de traitement par pression négative V.A.C.® à un traitement d'appoint avec la thérapie d'instillation V.A.C. ... Read more »

New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved blood glucose control as monotherapy and in combination with metformin, in Asian people from China, Malaysia and the Philippines with Type 2 Diabetes.

INGELHEIM, Germany & INDIANAPOLIS, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-US and Non-UK Media

Boehringer Ingelheim and Eli Lilly and Company today presented results from two randomised Phase III clinical trials evaluating the efficacy and safety of linagliptin in Asians from China, Malaysia and the Philippines with Type 2 Diabetes (T2D). The results showed that adults with T2D treated with linagliptin both as monotherapy and in combination with metformin achieved improved blood glucose control compared with placebo.

The rate of Type 2 Diabetes is rapidly increasing in Asia with the present trend indicating that more than 60% of the world’s diabeti ... Read more »

Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed reduction in required insulin dose in treated study subjects

INGELHEIM, Germany & Indianapolis, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE/ME NewsWire)-- For Non-US and Non-UK Media

Boehringer Ingelheim and Eli Lilly and Company today announced results of a 78-week Phase III clinical trial of the investigational compound empagliflozin* as an add-on to basal insulin in people with Type 2 Diabetes (T2D). The study, presented at the American Diabetes Association (ADA) 73rd Scientific Sessions®, showed that empagliflozin 10mg and 25mg, produced statistically significant reductions in HbA1c (average blood glucose), compared to placebo as add-on to basal insulin, at the time of assessment Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed reduction in required insulin dose in treated study subjects

of the ... Read more »

Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed reduction in body weight and systolic blood pressure in treated study subjects

INGELHEIM, Germany & INDIANAPOLIS, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE/ME NewsWire)-- For Non-US and Non-UK Media

Boehringer Ingelheim and Eli Lilly and Company today announced results of a 24-week Phase III clinical trial, which showed that treatment with the investigational compound empagliflozin* as monotherapy produced statistically significant reductions in HbA1c (average blood glucose) versus placebo, in patients with Type 2 Diabetes (T2D) who had not received any treatment for at least 12 weeks prior to randomisation.1

Empagliflozin is a member of the sodium glucose cotransporter 2 (SGLT2) inhibitor class of drugs and is being investigated for the reduction of blood glucose levels in adults with T2D. The emerging SGLT2 inhibitor class removes excess gluc ... Read more »

Data presented at American Diabetes Association 73rd Scientific Sessions® also showed reductions in weight and blood pressure


INGELHEIM, Germany & INDIANAPOLIS, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-US and Non-UK Media

Boehringer Ingelheim and Eli Lilly and Company today announced results of a 52-week Phase III clinical trial of the investigational compound empagliflozin*, which showed statistically significant reductions in HbA1c (average blood glucose) at week 24, with the addition of empagliflozin to existing oral glucose-lowering therapy in people with Type 2 Diabetes (T2D) and mild to moderate renal impairment as measured by the estimated glomerular filtration rate (eGFR ≥60 to <90mL/min/1.73m2 and eGFR ≥30 to <60mL/min/1.73 m2).1

Empagliflozin is a member of the sodium glucose cotransporter 2 (SGLT2) inhibitor class of drugs and is being investigated for the reduction of blood glucose levels in adults ... Read more »

Active clamp structure prevents overvoltage when inductive load is switched off

TOKYO - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Toshiba Corporation (TOKYO: 6502) today announced that it has launched a MOSFET, "SSM3K337R", for relay drivers. The new device uses an active clamp structure that prevents overvoltage when the inductive load of relay devices is switched off. Sample is available and mass production is scheduled to start in September. Demand for relay drivers is growing for automobile, since the number of electric components equipped by automobile is increasing. The "SSM3K337R" reduces ON-resistance by half and improves allowable power dissipation to approximately 1.6 times that of equivalent products.
 

Key Features

1.
          

Active clamp structure reduces stress by inductive load of relay devices.

2.
          

ON-resistance ... Read more »

L'étude révèle que les manchons de compression séquentielle réduisent les cas de thrombose veineuse profonde chez les patients immobilisés à la suited'une attaque

MANSFIELD, Massachussetts - Dimanche 23 Juin 2013 [ME NewsWire]

(BUSINESS WIRE)--Covidien (NYSE : COV), chef de file mondial dans la fabrication de produits de soins de santé, annonce ce jour qu'une étude indépendante menée par l'université d'Édimbourg a permis de démontrer l'efficacité du système Kendall SCD™ de Covidien utilisé avec la technologie de détection de remplissage vasculaire chez les patients immobilisés à la suite d'une attaque.

Les résultats de l'étude CLOTS 3 ont été présentés lors de la European Stroke Conference par le Professeur Martin S. Dennis du département de neurosciences cliniques de l'université d'Édimbourg ... Read more »

Data presented at the American Diabetes Association (ADA) 73rd Scientific Sessions® provides insights for use of Trajenta® (linagliptin) in adults with Type 2 Diabetes (T2D) with moderate to severe renal impairment

INGELHEIM, Germany & INDIANAPOLIS, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-U.S. and Non-UK media

Boehringer Ingelheim and Eli Lilly and Company today announced results from a new study that demonstrated linagliptin showed statistically significant reduction in blood glucose levels (HbA1C) in adult patients with Type 2 Diabetes (T2D) with moderate to severe renal impairment (RI), compared with those receiving placebo (12 weeks). Most patients had T2D for more than ten years (76%) and were on insulin (86%). After 12 weeks, patients on placebo switched to glimepiride up to 52 weeks. The study found that patients treated with linagliptin had lower rates of hypoglycaemia and less weight gain than those who received g ... Read more »

Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed statistically significant reductions in mean daily glucose and body weight in treated study subjects

INGELHEIM, Germany and INDIANAPOLIS, US - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-US and Non-UK Media

Boehringer Ingelheim and Eli Lilly and Company today announced results of two Phase III 24-week clinical trials of the investigational compound empagliflozin* added to metformin with and without the addition of sulphonylurea, respectively, in people with Type 2 Diabetes (T2D). These results showed statistically significant reductions in blood glucose among people who received empagliflozin, as measured by reductions in HbA1c (average blood glucose) after 24 weeks.1,2

Empagliflozin is a member of the sodium glucose cotransporter 2 (SGLT2) inhibitor class of drugs and is being investigated for the reduction of blood glucose levels in adults wi ... Read more »

Brand President Charlie Denson to retire in 2014

BEAVERTON, Ore. - Friday, June 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- NIKE, Inc. (NYSE: NKE) announced today that Charlie Denson, NIKE Brand President since 2006 and a 34-year veteran of the brand, will retire in January 2014. In conjunction with Denson’s decision to retire, the Company also announced strategic changes in its executive management team as part of the Company’s long-term organizational strategy to align the business to continue to drive growth. The changes reflect the Company’s focus on the consumer by accelerating innovation, elevating design, aligning product and merchandising excellence, optimizing go-to-market strategies and sharpening focus on supply chain and manufacturing capabilities.

Effective July 1, 2013, Trevor Edwards, currently the EVP of Brand and Category Management, will become the new NIKE Brand President leading all category and geographic business units, the Jordan Brand, Action ... Read more »

Study Shows Sequential Compression Sleeves Reduce DVT Events in Immobile Stroke Patients

MANSFIELD, Mass. - Saturday, June 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that an independent study conducted by the University of Edinburgh has successfully demonstrated the effectiveness of Covidien’s Kendall SCD™ system with Vascular Refill Detection Technology on immobile stroke patients.

The results of the CLOTS 3 trial were presented at the European Stroke Conference by Professor Martin S. Dennis of the University of Edinburgh’s Division of Clinical Neurosciences and also published in The Lancet. The new study showed a 29.9% decrease in the development of proximal deep vein thrombosis (DVT) in immobile stroke patients who received intermittent pneumatic compression (IPC) using the Kendall SCD system with Vascular Refill Detection Technology, which delivers sequential, circumferential ... Read more »

Une nouvelle fonctionnalité modernise le déroulement du travail et améliore la sécurité des patients DIA 2013

RESEARCH TRIANGLE PARK, Caroline du Nord - Dimanche 23 Juin 2013 [ME NewsWire]

(BUSINESS WIRE)--Quintiles a annoncé aujourd'hui une nouvelle fonctionnalité d'amélioration de la gestion des laboratoires pour les sites d'investigation, accessible par le biais de sa plateforme technologique primée, Quintiles Infosario® . Infosario rassemble de manière uniforme les données, les processus et l'expertise thérapeutique de Quintiles, afin de permettre des prises de décision plus rapides et mieux avisées durant tout le cycle de mise au point du médicament. Grâce à Infosario, les investigateurs et le personnel du site ont désormais la possibilité de commander des tests, de suivre des échantillons et d'accéder aux résultats sur un portail I ... Read more »

ABU DHABI, United Arab Emirates - Friday, June 21st 2013 [ME NewsWire]

In its fourth meeting for 2013, the Integrated Services Centre Supreme Committee at the Ministry of Interior endorsed the engineering plans for the Center’s building.  

During the meeting, chaired by Major General Ahmed Nasser Al Raisi, Director General of Electronics and Telecommunications Services, the committee also discussed the operational requirements, and the plans to establish a mini services center in Bani Yas, pending the completion of the Integrated Services Center’s main building.

The Committee tackled the various aspects related to the comprehensive employee issue, who will provide all types of services to the public. It also reviewed the issue of the competition launched recently to choose the Center’s name; noting that the winning design will soon be announced.

Major General Ahmad Al Raisi underscored the police leadership’s attention to the project, stressing the impo ... Read more »

• GE Healthcare fournira une solution de qualité à un prix abordable tout en élargissant son portefeuille de produits par l'acquisition d'un système de mammographie numérique unique • Cette acquisition reflète la stratégie de croissance de GE Korea, « In Korea, For the World ». • Ce partenariat mutuellement bénéfique créera une plateforme qui permettra à Rayence de pénétrer les marchés étrangers grâce à un contrat de fourniture de détecteurs CMOS

SÉOUL, Corée - Dimanche 23 Juin 2013 [ME NewsWire]

(BUSINESS WIRE)--GE Healthcare (NYSE : GE) a annoncé aujourd'hui son accord en vue de l'acquisition de certains actifs Mammographie de Rayence, une filiale de Vatech Co Ltd (KOSDAQ : 043150), un fabricant coréen d'équipement radiographique. À la conclusion de la transaction, ces actifs seront intégrés à la division Detection & Guidance Solutions ... Read more »

Reviewed by Saif bin Zayed who called for further excellence

ABU DHABI, United Arab Emirates - Saturday, June 22nd 2013 [ME NewsWire]

Lt. General HH Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Interior, was recently handed over at his office, the P3M3 International Accreditation awarded to Abu Dhabi Police by the UK Cabinet Office’s Association for Project Management. This accreditation recognizes the Abu Dhabi Police’s unique new achievement, as the first police institution in the Middle East to obtain this leading international certificate.

H.E Major General Nasser Lakhrebani Al Nuaimi, Secretary General of the Office of Deputy Prime Minister and Minister of Interior and Major General Khalil Dawood Badran, Director General of Finance and Services at Abu Dhabi Police dedicated this accreditation to His Highness and handed him the certificate.

His Highness lauded the efforts of the joint work team formed in collaboration with the ... Read more »

ABU DHABI, United Arab Emirates - Friday, June 21st 2013 [ME NewsWire]

A Ministry of Interior’s delegation reviewed the Dubai Municipality experience and best practices in the area of knowledge. The delegation was led by Col. Dr. Matar Humaid Al Shamsi, Deputy Chairman of the Standing Committee for Knowledge at the Knowledge Center, affiliated to the Strategy and Performance Development Department at the Ministry of Interior.

Colonel Al Shamsi lauded the efforts of Dubai Municipality and its prominent position in the areas of excellence as a leading institution, which has been vitally instrumental in the Dubai Emirate’s growth and development. He indicated that the visit aims to undertake a standard comparison, in line with the external communication methodology, and drawing on best practices and successful experiences.

The visiting delegation was briefed on the organizational structure of the Knowledge Center, its strategy and objectives. It also discussed the tas ... Read more »

New Functionality Streamlines Workflow, Speeds Results and Improves Patient Safety

RESEARCH TRIANGLE PARK, N.C. - Saturday, June 22nd 2013 [ME NewsWire]

DIA 2013

(BUSINESS WIRE)-- Quintiles today announced new functionality that improves laboratory management for investigator sites, delivered by its award-winning Quintiles Infosario® technology platform. Infosario seamlessly combines data, processes and Quintiles’ therapeutic expertise to enable faster, better-informed decisions across the drug development lifecycle. With Infosario, investigators and site personnel now have the ability to order tests, track samples and view results within one secure, online portal.

"The investigators working with Quintiles’ Global Laboratory network can now experience the benefits of streamlined communications, improved data accuracy and accelerated laboratory tests results,” said Thomas Wollman, Senior Vice President, Quintiles Global Laboratories and Cardiac Safety Ser ... Read more »

Study to Compare Traditional Negative Pressure Wound Therapy to V.A.C. VeraFlo™ Instillation Therapy, using the V.A.C.Ulta™ Negative Pressure Wound Therapy System

SAN ANTONIO - Thursday, June 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Kinetic Concepts, Inc. announced today the initiation of patient enrollment in a multi-center clinical study assessing the benefits of negative pressure wound therapy (NPWT) with intermittent instillation therapy with a topical wound cleanser. The randomized, controlled prospective study involves six investigative centers across the United States and compares traditional NPWT with V.A.C.® Negative Pressure Wound Therapy to adjunctive treatment with V.A.C. VeraFlo™ Instillation Therapy using the V.A.C.Ulta™ Negative Pressure Wound Therapy System for wounds that require hospital admission and serial surgical debridement.

This study follows an independent retrospective, historical cohort-controlled study recently presented at the 201 ... Read more »